{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:00:27Z","timestamp":1781082027062,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["AB22035078"],"award-info":[{"award-number":["AB22035078"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project","award":["S2017077"],"award-info":[{"award-number":["S2017077"]}]},{"name":"Guangxi Nanning Qingxiu District Science and Technology Development Project","award":["2014S06"],"award-info":[{"award-number":["2014S06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13300-026-01866-4","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:36:44Z","timestamp":1776847004000},"page":"839-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis"],"prefix":"10.1007","volume":"17","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"1866_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/biomedicines14010250","volume":"14","author":"C Tudoran","year":"2026","unstructured":"Tudoran C, Cozma D. Connections between diabetes mellitus, other metabolic and endocrine dysfunctions and cardiovascular pathologies-second edition. Biomedicines. 2026;14(1):250.","journal-title":"Biomedicines"},{"issue":"1","key":"1866_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12872-025-05389-x","volume":"26","author":"C Fan","year":"2025","unstructured":"Fan C, Yan H, Lei K, et al. In-hospital outcomes of percutaneous coronary intervention in acute coronary syndrome patients with heart failure: a real-world observational study from the CCC-ACS registry. BMC Cardiovasc Disord. 2025;26(1):62.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1866_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/medicina62010069","volume":"62","author":"RR Alrasheed","year":"2025","unstructured":"Alrasheed RR, Altaf AF, Althurwi AH, et al. Heart failure outcomes with SGLT2 inhibitors in adults with type 2 diabetes: a systematic review and meta-analysis. Medicina (Kaunas). 2025;62(1):69.","journal-title":"Medicina (Kaunas)."},{"issue":"12","key":"1866_CR4","volume":"17","author":"FMA Makhsham","year":"2025","unstructured":"Makhsham FMA, Nasr KAB, Al-Sewaiee AAS, et al. Impact of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) on cardiovascular outcomes in heart failure with reduced ejection fraction under contemporary standard care: a systematic review and meta-analysis. Cureus. 2025;17(12):e99014.","journal-title":"Cureus"},{"key":"1866_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000001179","author":"HZ Whiteson","year":"2026","unstructured":"Whiteson HZ, Frishman WH. The evolving guidelines for listing for heart transplantation: a review. Cardiol Rev. 2026. https:\/\/doi.org\/10.1097\/CRD.0000000000001179.","journal-title":"Cardiol Rev"},{"issue":"9","key":"1866_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.890359","volume":"9","author":"R Rivinius","year":"2022","unstructured":"Rivinius R, Gralla C, Helmschrott M, et al. Pre-transplant type 2 diabetes mellitus is associated with higher graft failure and increased 5-year mortality after heart transplantation. Front Cardiovasc Med. 2022;9(9):890359.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"1866_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"1866_CR8","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM,\u00a0et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"1866_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.18295\/squmj.10.2024.057","volume":"25","author":"MI Butt","year":"2025","unstructured":"Butt MI, Albalwi RMH, Alnassar N, Alghamdi R. Empagliflozin use in cardiac transplant patients:\u00a0real-world experience from Saudi Arabia. Sultan Qaboos Univ Med J. 2025;25(1):91\u20137.","journal-title":"Sultan Qaboos Univ Med J."},{"issue":"5","key":"1866_CR10","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1097\/TXD.0000000000000885","volume":"5","author":"MG Cehic","year":"2019","unstructured":"Cehic MG, Muir CA, Greenfield JR, et al. Efficacy and safety of empagliflozin in the management of diabetes mellitus in heart transplant recipients. Transplant Direct. 2019;5(5):e450.","journal-title":"Transplant Direct."},{"issue":"2","key":"1866_CR11","first-page":"242","volume":"41","author":"L You-Min","year":"2025","unstructured":"You-Min L, Chang C-Y, Chen M-F, et al. Are there any renoprotective effects of SGLT2 inhibitors in heart transplant recipients with diabetes? Acta Cardiol Sin. 2025;41(2):242\u201350.","journal-title":"Acta Cardiol Sin"},{"issue":"8","key":"1866_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2017.05.005","volume":"36","author":"CA Muir","year":"2017","unstructured":"Muir CA, Greenfield JR, MacDonald PS. Empagliflozin in the management of diabetes mellitus after cardiac transplantation research correspondence. J Heart Lung Transplant. 2017;36(8):914\u20136.","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"1866_CR13","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00246-024-03604-8","volume":"46","author":"DM Newland","year":"2025","unstructured":"Newland DM, Law YM, Albers EL, et al. Dapagliflozin use in children with advanced heart failure undergoing heart transplantation: a matched case-control study. Pediatr Cardiol. 2025;46(7):1879\u201384.","journal-title":"Pediatr Cardiol"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"100088","DOI":"10.1016\/j.jhlto.2024.100088","volume":"5","author":"LM Raven","year":"2024","unstructured":"Raven LM, Muir CA, Deveza RC, et al. Effect of sodium-glucose cotransporter 2 inhibition immediately prior to heart transplantation. JHLT Open. 2024;5:100088.","journal-title":"JHLT Open."},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.jhlto.2025.100255","volume":"8","author":"LM Raven","year":"2025","unstructured":"Raven LM, Greenfield JR, Jabbour A, Macdonald PS, Muir CA. Sodium-glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation. JHLT Open. 2025;8:100255.","journal-title":"JHLT Open."},{"issue":"5","key":"1866_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/joim.20077","volume":"297","author":"F-S Yen","year":"2025","unstructured":"Yen F-S, Hung Y-M, Huang J-Y, et al. Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes. J Intern Med. 2025;297(5):532\u201342.","journal-title":"J Intern Med"},{"issue":"2","key":"1866_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10741-024-10465-z","volume":"30","author":"E Alyaydin","year":"2025","unstructured":"Alyaydin E, Parianos D, Hermes-Laufer J, et al. Sodium-glucose co-transporter 2 inhibitors in left ventricular assist device and heart transplant recipients: a mini-review. Heart Fail Rev. 2025;30(2):327\u201335.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"1866_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.healun.2021.02.012","volume":"40","author":"Y Sammour","year":"2021","unstructured":"Sammour Y, Nassif M, Magwire M, et al. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: initial report from a cardiometabolic center of excellence. J Heart Lung Transplant. 2021;40(6):426\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"8540354","DOI":"10.1155\/jdr\/8540354","volume":"2026","author":"MJ Geum","year":"2026","unstructured":"Geum MJ, Oh KS, Ah Y-M. Sodium-glucose cotransporter 2 inhibitors in diabetic solid organ transplant recipients: a systematic review and meta-analysis of comparative studies. J Diabetes Res. 2026;2026:8540354.","journal-title":"J Diabetes Res."},{"key":"1866_CR20","doi-asserted-by":"crossref","unstructured":"R-L Liu,\u00a0Q-C Song,\u00a0K Yang,\u00a0et al. Empagliflozin supplementation in cardioplegic solution improves donor heart preservation by maintaining mitochondrial homeostasis. Cardiovasc Drugs Ther.\u00a02026.","DOI":"10.1007\/s10557-026-07834-1"},{"key":"1866_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154936","volume":"127","author":"R Marfella","year":"2022","unstructured":"Marfella R, D\u2019Onofrio N, Trotta MC, et al. Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts. Metabolism. 2022;127:154936.","journal-title":"Metabolism"},{"issue":"1","key":"1866_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2022.100729","volume":"37","author":"Y Lin","year":"2023","unstructured":"Lin Y, Mok M, Harrison J, et al. Use of sodium-glucose co-transporter 2 inhibitors in solid organ transplant recipients with pre-existing type 2 or post-transplantation diabetes mellitus: a systematic review. Transplant Rev (Orlando). 2023;37(1):100729.","journal-title":"Transplant Rev (Orlando)"},{"key":"1866_CR23","first-page":"e013747","volume":"2026","author":"EM DeFilippis","year":"2026","unstructured":"DeFilippis EM, Cheng RK, Donald EM, et al. Mitigating risk of kidney dysfunction after heart transplantation and therapeutic approaches. Circ Heart Fail. 2026;2026:e013747.","journal-title":"Circ Heart Fail."}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01866-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:23:06Z","timestamp":1781079786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01866-4","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Hong Wang, Xiaoya Xie, Guoping Gong, Liuqiang Huang, and Zhangui Tang have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Therefore, an ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}